Titre :
  • Magnitude of Trastuzumab Benefit in Patients With HER2-Positive, Invasive Lobular Breast Carcinoma: Results From the HERA Trial.
Auteur : Metzger-Filho, Otto ; Procter, Marion ; Azambuja, Evandro ; Leyland-Jones, Brian ; Gelber, Richard D ; Dowsett, Mitchell ; Loi, Sherene ; Saini, Kamal S ; Cameron, David A ; Untch, Michael ; Smith, Ian ; Gianni, Luca ; Baselga, José ; Jackisch, Christian ; Bell, Richard H ; Sotiriou, Christos ; Viale, Giuseppe ; Piccart-Gebhart, Martine
Informations sur la publication : Journal of clinical oncology, 31, 16, (page 1954-1960)
Statut de publication : Publié, 2013-06
Sujet CREF : Cancérologie
Sciences biomédicales
Mots-clés MeSH : Adult
Aged
Antibodies, Monoclonal, Humanized -- therapeutic use
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- chemistry -- drug therapy -- pathology
Carcinoma, Ductal, Breast -- chemistry -- drug therapy -- pathology
Carcinoma, Lobular -- chemistry -- drug therapy -- pathology
Disease-Free Survival
Female
Follow-Up Studies
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Lymphatic Metastasis
Middle Aged
Neoplasm Invasiveness
Proportional Hazards Models
Receptor, ErbB-2 -- analysis
Receptors, Estrogen -- analysis
Receptors, Progesterone -- analysis
Survival Analysis
Treatment Outcome
Tumor Markers, Biological -- analysis
Note : Journal Article
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:doi/10.1200/JCO.2012.46.2440
info:pii/JCO.2012.46.2440
info:pmid/23589556